K–9 Hero Act of 2026
Summary
The K–9 Hero Act of 2026 is an early-stage bill introduced in the House that would authorize a grant program for veterinary expenses of retired federal working dogs. It has been referred to committee with no cosponsors, no specific funding amount, and no identified market impact. The bill is procedural and unlikely to generate near-term investment signals.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.No specific funding amount is authorized or appropriated in this bill.
- 2.The bill has no cosponsors and is in the earliest legislative stage — extremely low probability of near-term enactment.
- 3.No publicly traded company has identifiable revenue exposure to this legislation.
Market Implications
No market implications at this stage. The bill is purely procedural and has no mechanism to affect any public company's revenue, costs, or competitive position. The absence of a funding amount and the lack of cosponsors indicate negligible near-term probability of enactment.
Full Analysis
What happened: On July 14, 2026, Rep. Derrick Van Orden (R-WI) introduced H.R. 9664, the K–9 Hero Act of 2026, in the House. The bill was referred to the House Committee on Oversight and Government Reform. This is an early-stage authorization bill with no companion legislation in the Senate. The bill text establishes a grant program to assist with veterinary expenses for retired federal working dogs, citing approximately 5,100 working dogs across 40 federal programs. No specific dollar amount is authorized in the bill text.
Money trail: The bill authorizes a grant program but does not specify a funding ceiling or appropriate any money. Actual funding would require a separate appropriations act. Without a dollar figure, the program's scale cannot be assessed. There is no direct revenue impact for any publicly traded company. Veterinary service providers (e.g., VCA Animal Hospitals, Banfield Pet Hospital) are not named and the program would likely be small relative to the overall pet-care market.
Convergence: No related signals or procurement activities were provided in the context data. This bill is currently isolated.
Structural winners and losers: No specific companies are identifiable as direct beneficiaries at this stage. The program would primarily affect non-public entities such as federal agencies and their contracted veterinary services. The bill lacks both authorization of specific funding and any mechanism that ties to a publicly traded company's revenue stream.
Timeline: The bill is in the earliest legislative stage — referred to a House committee. No hearings, markup, or floor votes have occurred. Passage in the 119th Congress is highly uncertain. Even if passed, implementing regulations and appropriations would take additional months or years.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $773M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $874M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $903M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $641M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $598M Department of Veterans Affairs Contract
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
Proclamation: Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →